Results per Page:
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
New projects advance health equity research
Two $1M grants support efforts to pinpoint novel prostate cancer biomarkers, improve clinical trial enrollment and inclusion
Dr. Ruth Etzioni receives $7.4M NCI grant to assess new cancer diagnostics
Award will provide long-term support to investigate accuracy of multi-cancer liquid biopsies and other new technology
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
CD133 auto-antibodies shine a light on early-stage small cell lung cancer
From the Dr. Paul D Lampe, Dr. Christopher Li, and Dr. A McGarry Houghton Labs, Cancer Epidemiology, Prevention and Control and Cancer Immunology Programs, Cancer Consortium.
Dr. Yingye Zheng named fellow of American Statistical Association
Honored for work to develop biomedical decision tools
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers
Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Glory's gift: Colon cancer patient's enduring legacy
A young woman’s resolve to help find a better way to detect colon cancer led to a years-long relationship between her family and a researcher across the country